Review




Structured Review

Galectin Therapeutics novel small molecule galectin 3 inhibitor
Compartment-specific functions <t>of</t> <t>Galectin-3</t> and therapeutic targeting strategies in prostate cancer.
Novel Small Molecule Galectin 3 Inhibitor, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/novel+small+molecule+galectin+3+inhibitor/pmc13206608-20-17-20?v=Galectin+Therapeutics
Average 86 stars, based on 1 article reviews
novel small molecule galectin 3 inhibitor - by Bioz Stars, 2026-08
86/100 stars

Images

1) Product Images from "Prostate Cancer Biomarkers with a Focus on Galectin-3: Emerging Clinical and Therapeutic Implications"

Article Title: Prostate Cancer Biomarkers with a Focus on Galectin-3: Emerging Clinical and Therapeutic Implications

Journal: Current Oncology

doi: 10.3390/curroncol33050280

Compartment-specific functions of Galectin-3 and therapeutic targeting strategies in prostate cancer.
Figure Legend Snippet: Compartment-specific functions of Galectin-3 and therapeutic targeting strategies in prostate cancer.

Techniques Used:



Similar Products

86
Galectin Therapeutics novel small molecule galectin 3 inhibitor
Compartment-specific functions <t>of</t> <t>Galectin-3</t> and therapeutic targeting strategies in prostate cancer.
Novel Small Molecule Galectin 3 Inhibitor, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/novel+small+molecule+galectin+3+inhibitor/pmc13206608-20-17-20?v=Galectin+Therapeutics
Average 86 stars, based on 1 article reviews
novel small molecule galectin 3 inhibitor - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


Compartment-specific functions of Galectin-3 and therapeutic targeting strategies in prostate cancer.

Journal: Current Oncology

Article Title: Prostate Cancer Biomarkers with a Focus on Galectin-3: Emerging Clinical and Therapeutic Implications

doi: 10.3390/curroncol33050280

Figure Lengend Snippet: Compartment-specific functions of Galectin-3 and therapeutic targeting strategies in prostate cancer.

Article Snippet: Lung & Pancreatic Cancer , KRAS Addiction: Gal-3 supports pro-survival pathways in KRAS-driven tumors. , GB1107 , Novel small molecule Galectin-3 inhibitor , Identified as a druggable vulnerability in hard-to-treat tumors, showing Gal-3 as a key mediator of oncogenic signaling beyond the AR pathway [ ]. .

Techniques: